lauric acid has been researched along with Peripheral Vascular Diseases in 2 studies
dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil.
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uemura, T | 1 |
| Takamatsu, H | 1 |
| Kawasaki, T | 1 |
| Taniguchi, M | 1 |
| Yamamoto, E | 1 |
| Tomura, Y | 1 |
| Uchida, W | 1 |
| Miyata, K | 1 |
| Adachi, H | 1 |
| Irie, T | 1 |
| Uekama, K | 1 |
| Manako, T | 1 |
| Yano, T | 1 |
| Saita, M | 1 |
2 other studies available for lauric acid and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Effect of YM-254890, a specific Galphaq/11 inhibitor, on experimental peripheral arterial disease in rats.
Topics: Animals; Aorta; Blood Flow Velocity; Blood Pressure; Clopidogrel; Dermis; Dose-Response Relationship | 2006 |
Inhibitory effect of prostaglandin E1 on laurate-induced peripheral vascular occlusive sequelae in rabbits: optimized topical formulation with beta-cyclodextrin derivative and penetration enhancer HPE-101.
Topics: Administration, Topical; Alprostadil; Animals; Cyclodextrins; Drug Carriers; Drug Combinations; Ear; | 1992 |